Skip to content
Head to head

Cardinal Health vs McKesson

Side-by-side on the measures that matter, with a plain-English read. Full detail: CAH · MCK

Updated 10 minutes ago

1-year performance, rebased to 100

CAH +33.6%MCK +25.5%
McKesson edges it on the scoreable measures. McKesson trades cheapest on trailing earnings; McKesson earns the most per share.
CAHMCK
Snapshot
SectorMedical Distribution--
Last price272.811,069.43
Change today+0.17%+0.68%
1-year return+32.4%+26.4%
Market cap$63.06B$123.47B
52-week range179.64 – 286.29722.11 – 1,121.50
Valuation
P/E (TTM)35.2927.48
P/E percentile, own 5-yr range72nd73rd
P/B-20.84-31.23
Dividend yield0.75%0.32%
Profitability & growth
EPS (TTM)7.2338.55
Net profit (TTM)$1.67B$4.45B
Revenue (TTM)$257.75B$418.79B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+5.5%+7.6%
Gross margin3.9%3.7%
Operating margin1.3%1.7%
Net margin0.7%1.1%
Free cash flow (TTM)$4.90B$6.87B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership90.5%89.2%
Insider activity (12mo)26 buy / 24 sell21 buy / 27 sell
Short interest (% of float)3.3%1.7%
Analyst consensus92% buy / 8% hold (12)90% buy / 10% hold (10)
Analyst price target$303 (+11%)$1,211 (+13%)
StockVane view
StockVane Quant RatingC (75)C (67)
Company
Employees63,90043,000
Founded19791833

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.